Drawing for H HURON

USPTO serial 87241259

H HURON

Reviewed by CopyMark Law Group

Reg. 5410134Status 702Registered
Filing date
Status date
Registration date
Feb 27, 2018
Examiner
OESTREICHER, SALIMA PARMAR
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with H HURON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melissa A. Vallone

Melissa A. Vallone BARNES & THORNBURG LLPP.O. BOX 2786CHICAGO, IL 60690United States

Goods and services

ClassDescriptionStatusFirst use
035consulting services in the field of higher education administration, business management of educational research, business organization, business expansion, all provided to higher education institutions; business management consulting and business consulting in the healthcare industry; business consulting services and information services provided to organizations in the healthcare field in the areas of corporate governance, human resource management, business management, economics, performance improvement and business strategy and operations; business research services provided to organizations in the healthcare field in the areas of business management, economics and business strategy and operations; consulting services to assist life sciences organizations and affiliates in the fields of business and program management, fair market value determination in the healthcare, pharmaceutical and life science fields; business consultation in the fields of product distribution management and distribution channel management; business consulting services to assist hospitals, academic medical centers and independent research organizations with operational and organizational effectiveness in the field of clinical research and compliance with government regulations, policies and procedures; business consulting in the field of clinical trials, namely, compilation and analysis of data in the field of clinical trials for business purposes; business consulting services in the field of clinical research billing compliance; business and management consulting in the field of facilitating revenue enhancement, business and organizational alignment, supply chain management, operational improvement, post-merger integration, post-emergence management and selling, general and administrative expenses efficiency; tax consultationACTIVESep 13, 2016
036consulting services provided to higher education institutions in the fields of financial management, budgeting and strategy; financial consulting services in the healthcare industry; real estate valuation services in the healthcare field; fair market value determination for fee for service activities, namely, financial valuation; cash management services in the healthcare industry; financial consulting services for forensic accounting, investigations and litigation; financial consulting services in the field of solutions to companies in transition, creditor constituencies, and other stakeholders in connection with out-of-court restructurings and bankruptcy proceedings; independent financial valuations and financial consulting services to assist clients in making informed decisions for transaction, tax or litigation purposesACTIVESep 13, 2016
045consulting services to assist life sciences organizations and affiliates in the fields of regulatory compliance to include aggregate spend disclosure reporting, corporate integrity agreements, Independent Review Organization procedures and Deferred Prosecution Agreements, and Government Price Reporting; consulting services, namely, advice for responsible and ethical clinical research and compliance with clinical research governmental regulations; consulting services, namely, assessment and implementation services for compliance with human research protection and an organization's committee that approves, monitors, and reviews biomedical and behavioral research involving humansACTIVESep 13, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 19, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 17, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 1, 2024E815TEAS SECTION 8 & 15 RECEIVED
Feb 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 2, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2017XAECEXAMINER'S AMENDMENT ENTERED
Nov 2, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 2, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Nov 2, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2017DOCKASSIGNED TO EXAMINER
Nov 26, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance